The emergence of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus amongst hospitalised immunocompromised patients in scotland, November-December, 2009

Eurosurveillance

Volumn 15, Issue 14, 2010, Pages

  Harvala, H ^a   Gunson, R ^b   Simmonds, P ^c   Hardie, A ^a   Bennett, S ^b   Scott, F ^d   Roddie, H ^d   McKnight, J ^d   Walsh, T ^a   Rowney, D ^e   Clark, A ^e,f   Bremner, J ^a   Aitken, C ^b   Templeton, K ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b West of Scotland Specialist Virology Laboratory Gartnavel   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d WESTERN GENERAL HOSPITAL   (United Kingdom)

^e ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

^f GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77951059644     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Centers for Disease Control and Prevention. Drug susceptibility of swine-origin influenza A (H1N1) viruses, April 2009. MMWR Morb Mortal Wkly Rep. 2009;58(16):433-5.
2. World Health Organization. Pandemic (H1N1) 2009: update 60. Geneva, Switzerland: World Health Organization; 2009. Available from: http://www.who.int/csr/don/2009_08_04/en/ index.html.
3. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis. 2009;15(2):155-62.
4. Meijer A, Lackenby A, Hungnes O, Lina B, van der Werf S, Schweiger B, et al. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis. 2009;15(4):552-60.
5. Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, et al. Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States. JAMA. 2009;301(10):1034-41.
6. Wang MZ, Tai CY, Mendel DB. Mechanism by which mutations at His274 alter sensitivity of influenza A virus N1 neuraminidase to oseltamivir carboxylate and zanamivir. Antimicrob Agents Chemother. 2002;46(12):3809-16.
7. McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother. 2003;47(7):2264-72.
8. Chen H, Cheung CL, Tai H, Zhao P, Chan JF, Cheng VC et al. Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus, Hong Kong, China. Emerg Infect Dis. 2009;15(12):1970-2.
9. Centers for Disease Control and Prevention. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis, September 2009. MMWR Morb Mortal Wkly Rep. 2009;58(35):969-72.
10. Le QM, Wertheim HF, Tran ND, van Doorn HR, Nguyen TH, Horby P; Vietnam H1N1 Investigation Team. A community cluster of oseltamivir-resistant cases of 2009 H1N1 influenza. N Engl J Med. 2010;362(1):86-7.
11. Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin M, Boivin G. Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis. N Engl J Med. 2009;361(23):2296-7.
12. World Health Organization. Pandemic (H1N1) 2009: briefing note 18, Geneva, Switzerland: World Health Organisation; 2009. http://www.who.int/csr/disease/swineflu/notes/ briefing_20091202/en/index.html.
13. Centers for Disease Control and Prevention. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients, August 2009. MMWR Morb Mortal Wkly Rep 2009;58(32):893-6.
14. van der Vries E, Jonges M, Herfst S, Maaskant J, van der Linden A, Gulgemeester J, et al. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J Clin Virol. 2010;47(1):34-7.
15. Baz M, Abed Y, Simon P, Hamelin M, Boivin G. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A (H1N1) viruses. J Infect Dis. 2010;201(5):740-115.